These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2653832)

  • 1. Gastrointestinal scintigraphy with 99mTc-DTPA labeled tablets in fed and fasting subjects.
    Maublant JC; Sournac M; Aiache JM; Veyre A
    Eur J Nucl Med; 1989; 15(3):143-5. PubMed ID: 2653832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissolution rate and transit times of technetium-99m DTPA-labeled tablets.
    Maublant JC; Sournac M; Aiache JM; Veyre A
    J Nucl Med; 1987 Jul; 28(7):1199-203. PubMed ID: 3298574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oesophageal transit of small tablets.
    Robertson CS; Hardy JG
    J Pharm Pharmacol; 1988 Aug; 40(8):595-6. PubMed ID: 2907022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combined analysis by ultrasonography and scintigraphy of a tablet along the digestive tract. Preliminary study with 4 cases].
    Maublant J; Dapony M; Sournac M; Goutay E; Hassine H; Aiache JM; Veyre A
    Ann Radiol (Paris); 1987; 30(6):410-2. PubMed ID: 3329486
    [No Abstract]   [Full Text] [Related]  

  • 5. Deposition and gastrointestinal transit of conventional sucralfate tablets.
    Vidgren M; Paronen P; Bergström K; Vainio P; Pikkarainen P
    Acta Pharm Nord; 1991; 3(2):83-6. PubMed ID: 1910551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scintigraphic evaluation of the in vivo performance of dry-coated delayed-release tablets in humans.
    Kambayashi A; Sako K; Kondo H
    Eur J Pharm Biopharm; 2020 Jul; 152():116-122. PubMed ID: 32380166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal transit of model mini-tablet controlled release oral dosage forms in fasted human volunteers.
    Podczeck F; Course N; Newton JM; Short MB
    J Pharm Pharmacol; 2007 Jul; 59(7):941-5. PubMed ID: 17637188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meal-induced acceleration of tablet transit through the human small intestine.
    Fadda HM; McConnell EL; Short MD; Basit AW
    Pharm Res; 2009 Feb; 26(2):356-60. PubMed ID: 18982248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pharmacoscintigraphic study of three time-delayed capsule formulations in healthy male volunteers.
    McConville JT; Hodges LA; Jones T; Band JP; O'Mahony B; Lindsay B; Ross AC; Florence AJ; Stanley AJ; Humphrey MJ; Wilson CG; Stevens HN
    J Pharm Sci; 2009 Nov; 98(11):4251-63. PubMed ID: 19387976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal arteriovenous transit times of technetium-radiolabeled chelates.
    Conrad GR; Wesolowski CA; Berbaum KS; Jensen KC; Kirchner PT
    J Nucl Med; 1987 Jul; 28(7):1134-43. PubMed ID: 3298571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal transit of Sinemet CR in healthy volunteers.
    Wilding IR; Davis SS; Melia CD; Hardy JG; Evans DF; Short AH; Sparrow RA
    Neurology; 1989 Nov; 39(11 Suppl 2):53-8. PubMed ID: 2685651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal transit of amoxicillin modified-release tablets and a placebo tablet including pharmacokinetic assessments of amoxicillin.
    Gottfries J; Svenheden A; Alpsten M; Bake B; Larsson A; Idström JP
    Scand J Gastroenterol; 1996 Jan; 31(1):49-53. PubMed ID: 8927940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive radionuclide esophagogastrointestinal transit study: methodology, reference values, and initial clinical experience.
    Antoniou AJ; Raja S; El-Khouli R; Mena E; Lodge MA; Wahl RL; Clarke JO; Pasricha P; Ziessman HA
    J Nucl Med; 2015 May; 56(5):721-7. PubMed ID: 25766893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of gamma scintigraphy to follow the gastrointestinal transit of pharmaceutical formulations.
    Christensen FN; Davis SS; Hardy JG; Taylor MJ; Whalley DR; Wilson CG
    J Pharm Pharmacol; 1985 Feb; 37(2):91-5. PubMed ID: 2858556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary clearance of inhaled 99mTc-DTPA: effects of surfactant depletion by lung lavage.
    Evander E; Wollmer P; Jonson B; Lachmann B
    J Appl Physiol (1985); 1987 Apr; 62(4):1611-4. PubMed ID: 3298194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between in vitro and in vivo erosion behaviour of erodible tablets using gamma scintigraphy.
    Ghimire M; Hodges LA; Band J; Lindsay B; O'Mahony B; McInnes FJ; Mullen AB; Stevens HN
    Eur J Pharm Biopharm; 2011 Jan; 77(1):148-57. PubMed ID: 20971189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple method for preparing radioactive capsules in colon transit study.
    Wang SJ; Tsai SC; Lin WY; Chen GH
    Eur J Nucl Med; 2000 Jul; 27(7):857-60. PubMed ID: 10952498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Diurnal Variation and Food on Gastrointestinal Transit of
    Kambayashi A; Sako K; Kondo H
    J Pharm Sci; 2020 Feb; 109(2):1020-1025. PubMed ID: 31600549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between severity of clinical symptoms and delay in gastric emptying in chronic gastritis; studied with 99mTc-DTPA scintigraphy.
    da Rocha AF; Zuccaro AM; Marquiotti M
    Eur J Nucl Med; 1986; 12(2):91-5. PubMed ID: 3525175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.